Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT02132234
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Sponsor
- Registry
-
NCT02132234
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- Poland
- Registry status
- Unknown status
Technical summary
Registry record NCT02132234. Randomized; triple masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2014-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
- Condition
- Rheumatoid Arthritis
- Condition
- Psoriatic Arthritis
- Condition
- Ankylosing Spondylitis
- Condition
- Hypertension
- Intervention (Drug)
- Etanercept
- Intervention (Drug)
- Adalimumab
- Intervention (Drug)
- Certolizumab
- Intervention (Drug)
- Infliximab
- Lead sponsor
- Jagiellonian University
- Collaborator
- Departmet of Rheumatology, J Dietl Hospital, Krakow, Poland
Record details
- Record id
cardio:ct-nct02132234- Content hash
55d706b0626edeac325393d738a59d3921fc5f8e4c0d2bd51998aec0bbdd5483